The Impact of GHRH on Sleep Promotion and Endocrine Regulation in Service Members Who Sustained a Traumatic Brain Injury and Have Current Insomnia

Trial Profile

The Impact of GHRH on Sleep Promotion and Endocrine Regulation in Service Members Who Sustained a Traumatic Brain Injury and Have Current Insomnia

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 14 Mar 2017

At a glance

  • Drugs Tesamorelin (Primary)
  • Indications Brain injuries
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Mar 2017 Planned primary completion date changed from 31 Dec 2018 to 8 Mar 2017.
    • 09 Mar 2017 Planned End Date changed from 31 Dec 2018 to 8 Mar 2017.
    • 09 Mar 2017 Status changed from not yet recruiting to withdrawn prior to enrolment.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top